We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01397201
Recruitment Status : Terminated
First Posted : July 19, 2011
Last Update Posted : May 16, 2014
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2011
  Study Completion Date : No date given
  Certification or Request for Extension to Delay Results Submission: April 30, 2014